losartan has been researched along with elastin in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 8 (61.54) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Keeley, FW; Leenen, FH; Ruzicka, M | 1 |
| Benessiano, J; Caputo, L; Duriez, M; Henrion, D; Heymes, C; Levy, BI; Poitevin, P; Samuel, JL | 1 |
| Alhenc Gelas, F; Huang, W; Osborne-Pellegrin, MJ | 1 |
| Amiri, F; Brassard, P; Schiffrin, EL | 1 |
| Che, ZQ; Gao, PJ; Han, WQ; Liu, JJ; Wu, LY; Wu, YJ; Zhang, J; Zhou, HY; Zhu, DL | 1 |
| Black, A; Byrne, J; Dietz, HC; Hill, AD; Huuskonen, V; Kay, E; Kearney, S; McAllister, H; McGuinness, J; McLoughlin, D; Redmond, JM; Terzo, E | 1 |
| Alvira, CM; Berry, GJ; Chin, JT; Dake, BA; Fischbein, MP; Iosef, C; Kimura, N; Maegdefessel, L; Merk, DR; Miller, MO; Mohr, FW; Robbins, RC; Spin, JM; Tsao, PS | 1 |
| Bustelo, XR; Campuzano, V; Coustets, M; Francke, U; Menacho-Márquez, M; Nevado, J; Pérez-Jurado, LA; Sánchez-Rodríguez, C; Segura-Puimedon, M; Terrado, V | 1 |
| Bricca, G; Dab, H; Dhaouadi, N; Hachani, R; Hodroj, W; Kacem, K; Randon, J; Sakly, M | 1 |
| Cassis, LA; Daugherty, A; Gong, MC; Guo, Z; Liu, S; Pearson, KJ; Xie, Z | 1 |
| Le, VP; Wagenseil, JE; Yamashiro, Y; Yanagisawa, H | 1 |
| Broekelmann, TJ; Halabi, CM; Knutsen, RH; Kozel, BA; Mecham, RP; Ye, L | 1 |
| Bradford, C; Falck, JR; Gotlinger, KH; Gupte, SA; Hunter, I; Hutcheson, B; Hutcheson, R; Joseph, G; Joshi, SR; Maniyar, R; Proctor, S; Rocic, P; Schwartzman, ML; Soler, A; Yang, J; Zhang, FF | 1 |
13 other study(ies) available for losartan and elastin
| Article | Year |
|---|---|
The renin-angiotensin system and volume overload-induced changes in cardiac collagen and elastin.
Topics: Aging; Animals; Biphenyl Compounds; Blood Pressure; Collagen; Coronary Circulation; Elastin; Enalapril; Heart Ventricles; Hyperemia; Imidazoles; Losartan; Male; Minoxidil; Myocardium; Rats; Rats, Wistar; Renin-Angiotensin System; Tetrazoles | 1994 |
Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Aorta, Thoracic; Biphenyl Compounds; Blood Pressure; Collagen; Elastin; Fibrosis; Hypertension; Hypertrophy; Imidazoles; Infusions, Parenteral; Losartan; Male; Muscle, Smooth, Vascular; Phenylephrine; Pyridines; Rats; Rats, Wistar; Reference Values; Tetrazoles | 1996 |
Protection of the arterial internal elastic lamina by inhibition of the renin-angiotensin system in the rat.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Aorta, Abdominal; Aorta, Thoracic; Aortic Rupture; Benzimidazoles; Blood Pressure; Body Weight; Calcium Channel Blockers; Collagen; Elastic Tissue; Elastin; Enalapril; Heart; Heart Rate; Losartan; Male; Mibefradil; Muscle, Smooth, Vascular; Organ Size; Peptidyl-Dipeptidase A; Rats; Rats, Inbred BN; Renin; Renin-Angiotensin System; Tetrahydronaphthalenes | 1998 |
Combined angiotensin II type 1 and type 2 receptor blockade on vascular remodeling and matrix metalloproteinases in resistance arteries.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Blotting, Western; Collagen Type I; Elasticity; Elastin; Fibronectins; Hydralazine; Losartan; Male; Matrix Metalloproteinase 2; Mesenteric Artery, Superior; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Vascular Resistance | 2005 |
Changes in the composition of the thoracic aortic wall in spontaneously hypertensive rats treated with losartan or spironolactone.
Topics: Animals; Antihypertensive Agents; Aorta, Thoracic; Blood Pressure; Collagen; Connective Tissue; Diuretics; Drug Evaluation, Preclinical; Elastin; Hypertension; Losartan; Muscle, Smooth, Vascular; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Spironolactone | 2009 |
Pravastatin reduces Marfan aortic dilation.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Aortic Diseases; Dilatation, Pathologic; Disease Models, Animal; Elastin; Endoplasmic Reticulum; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Losartan; Male; Marfan Syndrome; Mice; Mice, Mutant Strains; Muscle, Smooth, Vascular; Pravastatin; Treatment Outcome; Tunica Media | 2011 |
miR-29b participates in early aneurysm development in Marfan syndrome.
Topics: Age Factors; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Aortic Aneurysm; Apoptosis; Apoptosis Regulatory Proteins; Cells, Cultured; Disease Models, Animal; Elastin; Female; Fibrillin-1; Fibrillins; Genetic Therapy; Losartan; Male; Marfan Syndrome; Matrix Metalloproteinase 2; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microfilament Proteins; MicroRNAs; NF-kappa B; Oligonucleotides, Antisense; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Transforming Growth Factor beta; Up-Regulation | 2012 |
Reduction of NADPH-oxidase activity ameliorates the cardiovascular phenotype in a mouse model of Williams-Beuren Syndrome.
Topics: Acetophenones; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Arteries; Blood Pressure; Cardiomegaly; Constriction, Pathologic; Disease Models, Animal; Elastin; Enzyme Activation; Enzyme Inhibitors; Humans; Hypertension; Losartan; Mice; NADPH Oxidases; Oxidative Stress; Sequence Deletion; Williams Syndrome | 2012 |
Regulation of aortic extracellular matrix synthesis via noradrenergic system and angiotensin II in juvenile rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Collagen Type I; Collagen Type II; Collagen Type III; Elastin; Extracellular Matrix; Guanethidine; Losartan; Male; Rats; Rats, Inbred WKY; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sympathectomy; Sympathetic Nervous System | 2012 |
Mineralocorticoid receptor agonists induce mouse aortic aneurysm formation and rupture in the presence of high salt.
Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Aortic Aneurysm, Abdominal; Aortic Aneurysm, Thoracic; Aortic Rupture; Apoptosis; Blood Pressure; Desoxycorticosterone; Disease Models, Animal; Elastin; Enalapril; Eplerenone; Losartan; Male; Mice; Mice, Inbred C57BL; Mineralocorticoid Receptor Antagonists; Muscle, Smooth, Vascular; Oxidative Stress; Receptors, Mineralocorticoid; Sodium Chloride, Dietary; Spironolactone; Time Factors | 2013 |
Measuring, reversing, and modeling the mechanical changes due to the absence of Fibulin-4 in mouse arteries.
Topics: Animals; Aorta; Arteries; Biomechanical Phenomena; Captopril; Collagen; Elastic Modulus; Elastin; Extracellular Matrix Proteins; Female; Losartan; Male; Mice, Knockout; Models, Cardiovascular; Organ Specificity; Pressure; Stress, Mechanical | 2014 |
Chronic antihypertensive treatment improves pulse pressure but not large artery mechanics in a mouse model of congenital vascular stiffness.
Topics: Animals; Antihypertensive Agents; Arteries; Blood Pressure; Elastin; Losartan; Mice; Mice, Inbred C57BL; Nicardipine; Propranolol; Vascular Stiffness; Williams Syndrome | 2015 |
Elevated 20-HETE in metabolic syndrome regulates arterial stiffness and systolic hypertension via MMP12 activation.
Topics: Animals; Blood Pressure; Collagen Type I; Collagen Type III; Compliance; Cytochrome P-450 CYP4A; Cytochrome P450 Family 4; Diastole; Elastin; Enzyme Activation; Hydroxyeicosatetraenoic Acids; Hypertension; Losartan; Male; Matrix Metalloproteinase 12; Metabolic Syndrome; Proteolysis; Rats, Sprague-Dawley; RNA, Small Interfering; Vascular Stiffness | 2018 |